SCHEMBL20164036

SCHEMBL20164036

CN1CCC[C@H]1c1cncc(Br)c1.Cc1cncc([C@@H]2CCCN2C)c1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 5/20 0.56
CHRNA3 P32297 5/20 0.56
CHRNB2 P17787 5/20 0.56
CHRNA4 P43681 5/20 0.56
CHRNA1 P02708 4/20 0.56
CHRNA2 Q15822 3/20 0.56
CHRNG P07510 2/20 0.56
CHRNB1 P11230 2/20 0.56
CHRND Q07001 2/20 0.56
ALDH1A1 P00352 2/20 0.50
CHRNA7 P36544 2/20 0.50
LMNA P02545 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HTR3E A5X5Y0 1/20 0.50
PSIP1 O75475 1/20 0.50
TRPA1 O75762 1/20 0.50
HTR3B O95264 1/20 0.50
MAPT P10636 1/20 0.50
CYP2A6 P11509 1/20 0.50
PTGS1 P23219 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3058805 0.93 CHRNB2 (0.62) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL3058809 0.93 CHRNB2 (0.62) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL17264284 0.93 CHRNB2 (0.62) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL31019621 0.91 CHRNB4 (0.64) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL30866535 0.91 CHRNB4 (0.64) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL159158 0.91 CHRNB4 (0.64) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL159159 0.91 CHRNB4 (0.64) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
Acetic Acid SCHEMBL27199916 0.83 CHRNB4 (0.56) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
Acetic Acid SCHEMBL31344159 0.83 CHRNB4 (0.56) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1
SCHEMBL17258323 0.82 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200236936-A1 (S)-5-ETHYNYL-ANABASINE, DERIVATIVES THEREOF, AND RELATED COMPOSITIONS AND METHODS OF MAKING AND USING IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2020-07-30 US disclosed
US-10667515-B2 (S)-5-ethynyl-anabasine, derivatives thereof, and related compositions and methods of making and using IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-06-02 US disclosed
US-20190200611-A1 (S)-5-ETHYNYL-ANABASINE, DERIVATIVES THEREOF, AND RELATED COMPOSITIONS AND METHODS OF MAKING AND USING IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2019-07-04 US disclosed
US-20180139961-A1 (S)-5-ETHYNYL-ANABASINE, DERIVATIVES THEREOF, AND RELATED COMPOSITIONS AND METHODS OF MAKING AND USING IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10667515-B2 (S)-5-ethynyl-anabasine, derivatives thereof, and related compositions and methods of making and using AAAS, NANS, CIAPIN1 CHRNB4 2085/4885CHRNA3 2431/4885CHRNB2 2259/4885
US-20190200611-A1 (S)-5-ETHYNYL-ANABASINE, DERIVATIVES THEREOF, AND RELATED COMPOSITIONS AND METHODS OF MAKING AND USING AAAS, NANS, CIAPIN1 CHRNB4 2085/4885CHRNA3 2431/4885CHRNB2 2259/4885
US-20200236936-A1 (S)-5-ETHYNYL-ANABASINE, DERIVATIVES THEREOF, AND RELATED COMPOSITIONS AND METHODS OF MAKING AND USING AAAS, NANS, CIAPIN1 CHRNB4 2085/4885CHRNA3 2431/4885CHRNB2 2259/4885
US-20180139961-A1 (S)-5-ETHYNYL-ANABASINE, DERIVATIVES THEREOF, AND RELATED COMPOSITIONS AND METHODS OF MAKING AND USING AAAS, NANS, CIAPIN1 CHRNB4 2085/4885CHRNA3 2431/4885CHRNB2 2259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.